30 Results for "

benzenesulfonamide

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "benzenesulfonamide" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P1103
CAS No.: 1030384-98-5
Target:  

CXCR

Research Areas:  

Cancer

CTCE-9908 is a potent and selective CXCR4 antagonist. CTCE-9908 induces mitotic catastrophe, cytotoxicity and inhibits migration in CXCR4-expressing ovarian cancer cells .
loading...
    loading...
Cat. No.: HY-P4070
CAS No.: 1188379-43-2
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Insulin icodec is an Insulin (HY-P0035) analog that strongly but reversibly binds to albumin. Insulin icodec has long plasma half-life. Insulin icodec modulates insulin receptor activity, controls blood glucose levels, reduces HbA1c levels, and binds reversibly to human serum albumin. Insulin icodec can be used for the research of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-103001
CAS No.: 173528-92-2
Purity:  97.21%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.
loading...
    loading...
Cat. No.: HY-149269
CAS No.: 1160498-08-7
Research Areas:  

Inflammation/Immunology

COX-2-IN-30 is a benzenesulfonamide derivative, as well as an orally active and dual inhibitor of COX (IC50=49 nM for COX-2, 10.4 μM for COX-1) and 5-LOX (IC50=2.4 μM). COX-2-IN-30 also inhibits transmembrane hCA IX and hCA XII isoform with nanomolar calss Ki values. COX-2-IN-30 exhibits analgesic, anti-inflammatory, and ulcerogenic activities, and does not show acute gastric effect .
loading...
    loading...
Cat. No.: HY-162320
Target:  

PPAR

Research Areas:  

Metabolic Disease

PPARγ agonist 12 (compound 9i) is a potent and selective PPARγ agonist with EC50s of 3.98 and 15.42 μM against PPARγ and PPARδ, respectively. PPARγ agonist 12 improves insulin secretion and has anti-diabetic effect .
loading...
    loading...
Cat. No.: HY-P1103A
Target:  

CXCR

Research Areas:  

Cancer

CTCE-9908 TFA is a potent and selective CXCR4 antagonist. CTCE-9908 TFA induces mitotic catastrophe, cytotoxicity and inhibits migration in CXCR4-expressing ovarian cancer cells .
loading...
    loading...
Cat. No.: HY-P11293
CAS No.: 1309855-53-5
Target:  

Melanocortin Receptor

Research Areas:  

Cancer

DOTA-GGNle-CycMSHhex is a melanocortin-1 receptor (MC1R)-targeting peptide that can be radionuclide-labeled for melanoma imaging .
loading...
    loading...
Cat. No.: HY-P4757
CAS No.: 108081-77-2
Target:  

Parasite

Research Areas:  

Others

N1-Glutathionyl-spermidine disulfide is a substrate of trypanothione reductase .
loading...
    loading...
Cat. No.: HY-P1321
CAS No.: 158859-98-4
Synonyms: 1229U91; GW1229
Research Areas:  

Neurological Disease

GR231118, an analogue of the C-terminus of neuropeptide Y, is a potent , competitive and relative seletive antagonist at human neuropeptide Y Y receptor with a pKi of 10.4. GR231118 a potent agonist at the human neuropeptide Y Y4 receptor (pEC50=8.6; pKi=9.6) and a weak agonist at the human and rat neuropeptide YY2 and Y5 receptors. GR231118 also has high affinity for the mouse neuropeptide Y Y6 receptor (pKi= 8.8) .
loading...
    loading...
Cat. No.: HY-I0006R
CAS No.: 150727-06-3
Target:  

Reference Standards

N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide (Standard) is the analytical standard of N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide. This product is intended for research and analytical applications.
loading...
    loading...
Cat. No.: HY-W394717
CAS No.: 1186532-61-5
Synonyms: PGN 1531
Research Areas:  

Others

BGC-20-1531 (PGN 1531), a benzenesulfonamide derivative, is a selective EP4 antagonist. BGC-20-1531 binds to PGE2 enhancing the ATPase activity, which are coupled to Gs proteins and thus activate adenylate cyclase generating cAMP and activating PKA. BGC-20-1531 is promising for research of liver disorders .
loading...
    loading...
Cat. No.: HY-161814
Target:  

Apoptosis

Research Areas:  

Metabolic Disease

Apoptosis inducer 20 (12) causes G2/M cell cycle arrest and induction of apoptosis via caspase 3/7 activation, which occurred during M arrest. Apoptosis inducer 20 is a novel indolic benzenesulfonamide with anti-proliferative effect against a broad panel of cancer cell lines, which is proming for research of new anti-mitotic agents .
loading...
    loading...
Cat. No.: HY-W191560S
Synonyms: 4-Amino-N-(4-nitrophenyl)benzenesulfonamide-d4
N1-(4-Nitrophenyl)sulfanilamide-d4 is the deuterium labeled N1-(4-Nitrophenyl)sulfanilamide.
loading...
    loading...
Cat. No.: HY-159132
CAS No.: 3067730-65-5
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

CAIX/CAXII-IN-2 (compound 23) is a CAIX/CAXII inhibitor, with Ki values ​​of 8.9 nM and 5.3 nM for CAIX/CAXII, respectively. CAIX/CAXII-IN-2 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-146010
CAS No.: 2488872-31-5
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

Carbonic anhydrase inhibitor 13 (compound 7) is a potent carbonic anhydrase (CA) inhibitor, which features 3-methylthiazolo[3,2-a]benzimidazole moiety (as a tail) connected to the zinc anchoring benzenesulfonamide moiety via ureido linker .
loading...
    loading...
Cat. No.: HY-147961
CAS No.: 2417995-08-3
Target:  

COX

Research Areas:  

Inflammation/Immunology

COX-2-IN-23 (compound 9a) is a selective COX-2 inhibitor with IC50 values of 0.28 and 20.14 μM for COX-2 and COX-1. COX-2-IN-23 has anti-inflammatory activity and low ulcerogenic activity.
loading...
    loading...
Cat. No.: HY-148135
CAS No.: 694466-00-7
Purity:  ≥98.0%
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

CAI/II-IN-6 is an orally active human carbonic anhydrase (hCA) inhibitor. CAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5 and >50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. CAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. CAI/II-IN-6 can be used for the research of epilepsy .
loading...
    loading...
Cat. No.: HY-161522
CAS No.: 2375866-82-1
Research Areas:  

Endocrinology

α-Glucosidase-IN-63 (Compound 4d) is an inhibitor of α-Glucosidase (IC50=0.44 μM). α-Glucosidase-IN-63 inhibits hCA II with an activity of Ki= 7.0 nM. α-Glucosidase-IN-63 is orally effective. .
loading...
    loading...
Cat. No.: HY-W777823
CAS No.: 1287138-19-5
N-(a,a-Dimethylbenzyl)benzenesulfonamide- 13C6 is the 13C-labeled N-(2-Phenylpropan-2-yl)benzenesulfonamide (HY-W701611).
loading...
    loading...
Cat. No.: HY-W710871
CAS No.: 2733216-12-9
N,N-Bis(2-chloroethyl)benzenesulfonamide-d5 is the deuterium labeled N,N-Bis(2-chloroethyl)benzenesulfonamide (HY-W703633).
loading...
    loading...